PT-141 (Pregnanolone-3-Sulfate) – 10MG Research-Use-Only

PT-141, chemically known as pregna-5,20-dien-3α-ol-3-sulfate, is a synthetic analog of the naturally occurring neurosteroid pregnenolone. Originally developed as a potential therapeutic for conditions related to neuroendocrine function, PT-141 has gained attention in academic and biochemical research for its distinct pharmacological profile. This product is intended for use in academic, industrial, and research institutions solely for non-clinical studies. The information provided herein is for informational purposes only and is limited to its role in scientific and analytical research applications.

Research Context

PT-141 emerged from early studies examining neurosteroid modulation of reproductive and stress-related behaviors. Its structure differentiates it from traditional steroid analogs, allowing for targeted investigation into its effects on neuronal function, hormone signaling pathways, and potential therapeutic mechanisms in controlled research settings. Initial preclinical research explored its potential role in altering reproductive behaviors, though broader applications remain speculative in human contexts.

Research Overview

PT-141 has been characterized in vitro and in animal models for its ability to modulate neurosteroid receptor interactions, particularly influencing GABAergic signaling. Its synthetic nature permits precise formulation for research applications where natural neurosteroids exhibit variability. While PT-141’s primary research focus has centered on reproductive endocrinology, its structural and mechanistic properties make it a valuable tool for studying neurosteroid dynamics across multiple biological systems.

Key Research Focus Areas

• Investigation of neurosteroid receptor-mediated signaling pathways in reproductive physiology, including its potential effects on sexual behavior and hormonal regulation.
• Analysis of PT-141’s pharmacokinetics in controlled laboratory environments to assess stability, metabolism, and distribution in test subjects.
• Comparative study of PT-141’s structural analogs to elucidate mechanisms of neurosteroid modulation within GABAergic and related neuronal circuits.
• Development of experimental models to examine the role of PT-141 in stress-related behaviors and its interaction with endogenous neurosteroid production.
• Assessment of PT-141’s potential in preclinical research applications involving neuroendocrine function, particularly in controlled reproductive studies.

Important Safety and Compliance Notice

This product is intended exclusively for use in research and academic institutions by qualified personnel. PT-141 is not approved for human or animal consumption and should be handled with the utmost caution in accordance with local laboratory safety protocols. All experimental procedures involving PT-141 must comply with relevant ethical guidelines, regulatory requirements, and institutional biosafety standards. Proper documentation and record-keeping are mandatory for all research involving this compound.

For research use only. Not for human or animal consumption.